logo-loader
HealthPharma & Biotech
ITUS Corp

ITUS Corporation CEO Robert Berman presents at Biotech Capital Conference

ITUS Corporation CEO Robert Berman presents at Biotech Capital Conference 

Quick facts: ITUS Corp

Price: 0 0

Market: NASDAQ
Market Cap: £0.00
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Shield Therapeutics to present data showing Feraccru offers 'real oral...

Shield Therapeutics PLC's (LON:STX) Dr Mark Sampson speaks to Proactive London's Andrew Scott ahead of them presenting positive data from the Phase 3b, open-label randomised controlled trial of Feraccru. He says the trial shows the drug, also known as Accrufer in the States, offers a real...

14 hours, 50 minutes ago

2 min read